BR9811531A - Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga - Google Patents

Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga

Info

Publication number
BR9811531A
BR9811531A BR9811531-6A BR9811531A BR9811531A BR 9811531 A BR9811531 A BR 9811531A BR 9811531 A BR9811531 A BR 9811531A BR 9811531 A BR9811531 A BR 9811531A
Authority
BR
Brazil
Prior art keywords
human
preparation
homologous recombination
human cells
cells
Prior art date
Application number
BR9811531-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Anne Stern
Konrad Honold
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9811531(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of BR9811531A publication Critical patent/BR9811531A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
BR9811531-6A 1997-07-23 1998-07-22 Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga BR9811531A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112639 1997-07-23
PCT/EP1998/004583 WO1999005264A2 (de) 1997-07-23 1998-07-22 Herstellung humaner mutierter proteine in humanen zellen mittels homologer rekombination

Publications (1)

Publication Number Publication Date
BR9811531A true BR9811531A (pt) 2000-08-22

Family

ID=8227102

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811531-6A BR9811531A (pt) 1997-07-23 1998-07-22 Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga

Country Status (17)

Country Link
US (2) US6444441B1 (enExample)
EP (1) EP1000167B2 (enExample)
JP (1) JP2001511341A (enExample)
KR (1) KR100512018B1 (enExample)
CN (2) CN101348789B (enExample)
AR (2) AR013251A1 (enExample)
AT (1) ATE313643T1 (enExample)
AU (1) AU729489B2 (enExample)
BR (1) BR9811531A (enExample)
CA (1) CA2297660C (enExample)
DE (1) DE59813296D1 (enExample)
DK (1) DK1000167T4 (enExample)
ES (1) ES2255177T5 (enExample)
PT (1) PT1000167E (enExample)
TR (1) TR200000172T2 (enExample)
WO (1) WO1999005264A2 (enExample)
ZA (1) ZA986517B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102789754B1 (ko) * 2016-01-06 2025-03-31 론자 리미티드 개선된 생산을 위한 단백질 분해의 억제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
DE3907679A1 (de) * 1989-03-09 1990-09-13 Max Planck Gesellschaft Verfahren zur gezielten veraenderung eines gens
JPH0576361A (ja) * 1990-05-10 1993-03-30 Takeda Chem Ind Ltd 組織プラスミノーゲンアクチベータームテイン
US5612205A (en) 1990-08-29 1997-03-18 Genpharm International, Incorporated Homologous recombination in mammalian cells
WO1992020808A1 (en) * 1991-05-15 1992-11-26 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
DE69333955D1 (de) * 1992-04-24 2006-02-02 Stanford Res Inst Int Targeting homologer sequenzen in eukaryotenzellen
WO1994004032A1 (en) * 1992-08-21 1994-03-03 The Regents Of The University Of California Composition and method for altering dna sequences by homologous recombination
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
AU6328696A (en) * 1995-06-07 1996-12-30 Yale University Treatment of hemoglobinopathies
US6087129A (en) * 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines

Also Published As

Publication number Publication date
AU9067398A (en) 1999-02-16
AR013251A1 (es) 2000-12-13
US20020068318A1 (en) 2002-06-06
ATE313643T1 (de) 2006-01-15
EP1000167B1 (de) 2005-12-21
DK1000167T3 (da) 2006-04-24
PT1000167E (pt) 2006-05-31
DE59813296D1 (de) 2006-01-26
CN101348789B (zh) 2016-08-17
ES2255177T3 (es) 2006-06-16
US6444441B1 (en) 2002-09-03
CN1265152A (zh) 2000-08-30
EP1000167A2 (de) 2000-05-17
EP1000167B2 (de) 2011-04-20
WO1999005264A2 (de) 1999-02-04
CN101348789A (zh) 2009-01-21
TR200000172T2 (tr) 2000-12-21
KR100512018B1 (ko) 2005-09-02
CA2297660C (en) 2010-04-27
ES2255177T5 (es) 2011-07-12
KR20010022127A (ko) 2001-03-15
US20020177195A1 (en) 2002-11-28
ZA986517B (en) 2000-01-24
AR068104A2 (es) 2009-11-04
AU729489B2 (en) 2001-02-01
CA2297660A1 (en) 1999-02-04
JP2001511341A (ja) 2001-08-14
WO1999005264A3 (de) 1999-04-22
DK1000167T4 (da) 2011-08-08

Similar Documents

Publication Publication Date Title
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
AU2001278797A1 (en) Expression vector using for animal cell
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
DK58789D0 (da) Proteiner med faktor viii-aktivitet, fremgangsmaade til deres fremstilling ved anvendelse af genetisk konstruerede celler og farmaceutiske kompositioner indeholdende proteinerne
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
DK1200583T3 (da) Fremstilling af beta-foldeblad-proteiner med specifikke bindingsegenskaber
BR9812547A (pt) Proteìnas de fusão compreendendo proteìnas hiv-1 tat e/ou nef
DE69516847D1 (de) Chlorpyrimidine als zwischenprodukte
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
BR9712556A (pt) Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
ATE437951T1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
DE69505804D1 (de) Afamin: ein menschliches serum albumin ähnliches protein
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DK124787A (da) Peptider indeholdende op til 8-aminosyregrupperinger og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen
NO984491D0 (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
WO1994003601A3 (en) Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
EA200000270A1 (ru) КОМПОЗИЦИИ ДЛЯ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ СЕКРЕТИРУЕМЫЕ БЕЛКИ, ТАКИЕ КАК β-ИНТЕРФЕРОН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
BR9811531A (pt) Preparação de proteìnas mutadas humanas em células humanas por meio de recombinação homóloga
EP0770137A4 (en) IMPROVEMENTS IN PROTEIN PRODUCTION IN HOST CELLS
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
BR0303362A (pt) Composição e método para melhorar uma resposta imune em um animal, método para distribuir uma proteìna de carga em uma célula de animal, célula viva geneticamente modificada, e, método para a construção de uma proteìna de fusão para melhorar a resposta imune em um animal
ATE399794T1 (de) Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
AR034853A1 (es) Secuencia de acido nucleico sintetico que codifica una alfa-galactosidasa, vector y celula que la comprenden, metodo para producir alfa-galactosidasa, metodo para prepararla, composicion farmaceutica que comprende dicha secuencia y su uso para preparar esta ultima

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: COM BASE NO ART. 8O COMBINADO COM ART. 13 DA LPI 9279/96 E DE ACORDO COM O ART. 37 DA LPI, SUGERE-SE O INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE.

B12B Appeal against refusal [chapter 12.2 patent gazette]